OUTLOOK THERAPEUTICS (OTLK) SWOT Analysis / TOWS Matrix / MBA Resources

Introduction to SWOT Analysis

SWOT Analysis / TOWS Matrix for OUTLOOK THERAPEUTICS (United States)

Based on various researches at Oak Spring University , OUTLOOK THERAPEUTICS is operating in a macro-environment that has been destablized by – digital marketing is dominated by two big players Facebook and Google, increasing government debt because of Covid-19 spendings, there is backlash against globalization, challanges to central banks by blockchain based private currencies, supply chains are disrupted by pandemic , central banks are concerned over increasing inflation, geopolitical disruptions, technology disruption, increasing transportation and logistics costs, etc

---

---

---

---

Introduction to SWOT Analysis of OUTLOOK THERAPEUTICS

SWOT stands for an organization’s Strengths, Weaknesses, Opportunities and Threats . At Oak Spring University, we believe that OUTLOOK THERAPEUTICS can use SWOT analysis as a strategic management tool to assess the current internal strengths and weaknesses of the OUTLOOK THERAPEUTICS, and to figure out the opportunities and threats in the macro environment – technological, environmental, political, economic, social, demographic, etc in which OUTLOOK THERAPEUTICS operates in.

According to Harvard Business Review, 75% of the managers use SWOT analysis for various purposes such as – evaluating current scenario, strategic planning, new venture feasibility, personal growth goals, new market entry, Go To market strategies, portfolio management and strategic trade-off assessment, organizational restructuring, etc.

---

SWOT Objectives / Importance of SWOT Analysis and SWOT Matrix

SWOT analysis of OUTLOOK THERAPEUTICS can be done for the following purposes –
1. Strategic planning of OUTLOOK THERAPEUTICS
2. Improving business portfolio management of OUTLOOK THERAPEUTICS
3. Assessing feasibility of the new initiative in United States
4. Making a Biotechnology & Drugs sector specific business decision
5. Set goals for the organization
6. Organizational restructuring of OUTLOOK THERAPEUTICS

---

Strengths of OUTLOOK THERAPEUTICS | Internal Strategic Factors
What are Strengths in SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis

The strengths of OUTLOOK THERAPEUTICS are -

Successful track record of launching new products

– OUTLOOK THERAPEUTICS has launched numerous new products in last few years, keeping in mind evolving customer preferences and competitive pressures. OUTLOOK THERAPEUTICS has effective processes in place that helps in exploring new product needs, doing quick pilot testing, and then launching the products quickly using its extensive distribution network.

Sustainable margins compare to other players in Biotechnology & Drugs industry

– OUTLOOK THERAPEUTICS has clearly differentiated products in the market place. This has enabled OUTLOOK THERAPEUTICS to fetch slight price premium compare to the competitors in the Biotechnology & Drugs industry. The sustainable margins have also helped OUTLOOK THERAPEUTICS to invest into research and development (R&D) and innovation.

Organizational Resilience of OUTLOOK THERAPEUTICS

– The covid-19 pandemic has put organizational resilience at the centre of everthing OUTLOOK THERAPEUTICS does. Organizational resilience comprises - Financial Resilience, Operational Resilience, Technological Resilience, Organizational Resilience, Business Model Resilience, and Reputation Resilience.

Innovation driven organization

– OUTLOOK THERAPEUTICS is one of the most innovative firm in Biotechnology & Drugs sector.

Learning organization

- OUTLOOK THERAPEUTICS is a learning organization. It has inculcated three key characters of learning organization in its processes and operations – exploration, creativity, and expansiveness. The work place at OUTLOOK THERAPEUTICS is open place that encourages instructiveness, ideation, open minded discussions, and creativity. Employees and leaders at OUTLOOK THERAPEUTICS emphasize – knowledge, initiative, and innovation.

Low bargaining power of suppliers

– Suppliers of OUTLOOK THERAPEUTICS in the Healthcare sector have low bargaining power. OUTLOOK THERAPEUTICS has further diversified its suppliers portfolio by building a robust supply chain across various countries. This helps OUTLOOK THERAPEUTICS to manage not only supply disruptions but also source products at highly competitive prices.

High switching costs

– The high switching costs that OUTLOOK THERAPEUTICS has built up over years in its products and services combo offer has resulted in high retention of customers, lower marketing costs, and greater ability of the firm to focus on its customers.

Highly skilled collaborators

– OUTLOOK THERAPEUTICS has highly efficient outsourcing and offshoring strategy. It has resulted in greater operational flexibility and bringing down the costs in highly price sensitive Biotechnology & Drugs industry. Secondly the value chain collaborators of OUTLOOK THERAPEUTICS have helped the firm to develop new products and bring them quickly to the marketplace.

Ability to lead change in Biotechnology & Drugs

– OUTLOOK THERAPEUTICS is one of the leading players in the Biotechnology & Drugs industry in United States. Over the years it has not only transformed the business landscape in the Biotechnology & Drugs industry in United States but also across the existing markets. The ability to lead change has enabled OUTLOOK THERAPEUTICS in – penetrating new markets, reaching out to new customers, and providing different value propositions to different customers in the international markets.

High brand equity

– OUTLOOK THERAPEUTICS has strong brand awareness and brand recognition among both - the exiting customers and potential new customers. Strong brand equity has enabled OUTLOOK THERAPEUTICS to keep acquiring new customers and building profitable relationship with both the new and loyal customers.

Training and development

– OUTLOOK THERAPEUTICS has one of the best training and development program in Healthcare industry. The effectiveness of the training programs can be measured in – employees retention, in-house promotion, loyalty, new venture initiation, lack of conflict, and high level of both employees and customer engagement.

Strong track record of project management in the Biotechnology & Drugs industry

– OUTLOOK THERAPEUTICS is known for sticking to its project targets. This enables the firm to manage – time, project costs, and have sustainable margins on the projects.

---

---

Weaknesses of OUTLOOK THERAPEUTICS | Internal Strategic Factors
What are Weaknesses in SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis

The weaknesses of OUTLOOK THERAPEUTICS are -

Employees’ less understanding of OUTLOOK THERAPEUTICS strategy

– From the outside it seems that the employees of OUTLOOK THERAPEUTICS don’t have comprehensive understanding of the firm’s strategy. This is reflected in number of promotional campaigns over the last few years that had mixed messaging and competing priorities. Some of the strategic activities and services promoted in the promotional campaigns were not consistent with the organization’s strategy.

Slow decision making process

– As mentioned earlier in the report, OUTLOOK THERAPEUTICS has a very deliberative decision making approach. This approach has resulted in prudent decisions, but it has also resulted in missing opportunities in the Biotechnology & Drugs industry over the last five years. OUTLOOK THERAPEUTICS even though has strong showing on digital transformation primary two stages, it has struggled to capitalize the power of digital transformation in marketing efforts and new venture efforts.

Skills based hiring in Biotechnology & Drugs industry

– The stress on hiring functional specialists at OUTLOOK THERAPEUTICS has created an environment where the organization is dominated by functional specialists rather than management generalist. This has resulted into product oriented approach rather than marketing oriented approach or consumers oriented approach.

High dependence on OUTLOOK THERAPEUTICS ‘s star products

– The top 2 products and services of OUTLOOK THERAPEUTICS still accounts for major business revenue. This dependence on star products in Biotechnology & Drugs industry has resulted into insufficient focus on developing new products, even though OUTLOOK THERAPEUTICS has relatively successful track record of launching new products.

High operating costs

– Compare to the competitors, OUTLOOK THERAPEUTICS has high operating costs in the Biotechnology & Drugs industry. This can be harder to sustain given the new emerging competition from nimble players who are using technology to attract OUTLOOK THERAPEUTICS lucrative customers.

Compensation and incentives

– The revenue per employee of OUTLOOK THERAPEUTICS is just above the Biotechnology & Drugs industry average. It needs to redesign the compensation structure and incentives to increase the revenue per employees. Some of the steps that it can take are – hiring more specialists on project basis, etc.

Capital Spending Reduction

– Even during the low interest decade, OUTLOOK THERAPEUTICS has not been able to do capital spending to the tune of the competition. This has resulted into fewer innovations and company facing stiff competition from both existing competitors and new entrants who are disrupting the Biotechnology & Drugs industry using digital technology.

Ability to respond to the competition

– As the decision making is very deliberative at OUTLOOK THERAPEUTICS, in the dynamic environment of Biotechnology & Drugs industry it has struggled to respond to the nimble upstart competition. OUTLOOK THERAPEUTICS has reasonably good record with similar level competitors but it has struggled with new entrants taking away niches of its business.

Workers concerns about automation

– As automation is fast increasing in the Biotechnology & Drugs industry, OUTLOOK THERAPEUTICS needs to come up with a strategy to reduce the workers concern regarding automation. Without a clear strategy, it could lead to disruption and uncertainty within the organization.

Lack of clear differentiation of OUTLOOK THERAPEUTICS products

– To increase the profitability and margins on the products, OUTLOOK THERAPEUTICS needs to provide more differentiated products than what it is currently offering in the marketplace.

Increasing silos among functional specialists

– The organizational structure of OUTLOOK THERAPEUTICS is dominated by functional specialists. It is not different from other players in the Biotechnology & Drugs industry, but OUTLOOK THERAPEUTICS needs to de-silo the office environment to harness the true potential of its workforce. Secondly the de-silo will also help OUTLOOK THERAPEUTICS to focus more on services in the Biotechnology & Drugs industry rather than just following the product oriented approach.

---

OUTLOOK THERAPEUTICS Opportunities | External Strategic Factors
What are Opportunities in the SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis

The opportunities of OUTLOOK THERAPEUTICS are -

Remote work and new talent hiring opportunities

– The widespread usage of remote working technologies during Covid-19 has opened opportunities for OUTLOOK THERAPEUTICS to expand its talent hiring zone. According to McKinsey Global Institute, 20% of the high end workforce in fields such as finance, information technology, can continously work from remote local post Covid-19. This presents a really great opportunity for OUTLOOK THERAPEUTICS to hire the very best people irrespective of their geographical location.

Reforming the budgeting process

- By establishing new metrics that will be used to evaluate both existing and potential projects OUTLOOK THERAPEUTICS can not only reduce the costs of the project but also help it in integrating the projects with other processes within the organization.

Lowering marketing communication costs

– 5G expansion will open new opportunities for OUTLOOK THERAPEUTICS in the field of marketing communication. It will bring down the cost of doing business, provide technology platform to build new products in the Biotechnology & Drugs industry, and it will provide faster access to the consumers.

Using analytics as competitive advantage

– OUTLOOK THERAPEUTICS has spent a significant amount of money and effort to integrate analytics and machine learning into its operations in Biotechnology & Drugs sector. This continuous investment in analytics has enabled OUTLOOK THERAPEUTICS to build a competitive advantage using analytics. The analytics driven competitive advantage can help OUTLOOK THERAPEUTICS to build faster Go To Market strategies, better consumer insights, developing relevant product features, and building a highly efficient supply chain.

Creating value in data economy

– The success of analytics program of OUTLOOK THERAPEUTICS has opened avenues for new revenue streams for the organization in Biotechnology & Drugs industry. This can help OUTLOOK THERAPEUTICS to build a more holistic ecosystem for OUTLOOK THERAPEUTICS products in the Biotechnology & Drugs industry by providing – data insight services, data privacy related products, data based consulting services, etc.

Buying journey improvements

– OUTLOOK THERAPEUTICS can improve the customer journey of consumers in the Biotechnology & Drugs industry by using analytics and artificial intelligence. It can provide automated chats to help consumers solve their own problems, provide online suggestions to get maximum out of the products and services, and help consumers to build a community where they can interact with each other to develop new features and uses.

Developing new processes and practices

– OUTLOOK THERAPEUTICS can develop new processes and procedures in Biotechnology & Drugs industry using technology such as automation using artificial intelligence, real time transportation and products tracking, 3D modeling for concept development and new products pilot testing etc.

Manufacturing automation

– OUTLOOK THERAPEUTICS can use the latest technology developments to improve its manufacturing and designing process in Biotechnology & Drugs sector. It can use CAD and 3D printing to build a quick prototype and pilot testing products. It can leverage automation using machine learning and artificial intelligence to do faster production at lowers costs, and it can leverage the growth in satellite and tracking technologies to improve inventory management, transportation, and shipping.

Leveraging digital technologies

– OUTLOOK THERAPEUTICS can leverage digital technologies such as artificial intelligence and machine learning to automate the production process, customer analytics to get better insights into consumer behavior, realtime digital dashboards to get better sales tracking, logistics and transportation, product tracking, etc.

Loyalty marketing

– OUTLOOK THERAPEUTICS has focused on building a highly responsive customer relationship management platform. This platform is built on in-house data and driven by analytics and artificial intelligence. The customer analytics can help the organization to fine tune its loyalty marketing efforts, increase the wallet share of the organization, reduce wastage on mainstream advertising spending, build better pricing strategies using personalization, etc.

Low interest rates

– Even though inflation is raising its head in most developed economies, OUTLOOK THERAPEUTICS can still utilize the low interest rates to borrow money for capital investment. Secondly it can also use the increase of government spending in infrastructure projects to get new business.

Finding new ways to collaborate

– Covid-19 has not only transformed business models of companies in Biotechnology & Drugs industry, but it has also influenced the consumer preferences. OUTLOOK THERAPEUTICS can tie-up with other value chain partners to explore new opportunities regarding meeting customer demands and building a rewarding and engaging relationship.

Harnessing reconfiguration of the global supply chains

– As the trade war between US and China heats up in the coming years, OUTLOOK THERAPEUTICS can build a diversified supply chain model across various countries in - South East Asia, India, and other parts of the world. This reconfiguration of global supply chain can help OUTLOOK THERAPEUTICS to buy more products closer to the markets, and it can leverage its size and influence to get better deal from the local markets.

---

Threats OUTLOOK THERAPEUTICS External Strategic Factors
What are Threats in the SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis

The threats of OUTLOOK THERAPEUTICS are -

Learning curve for new practices

– As the technology based on artificial intelligence and machine learning platform is getting complex, OUTLOOK THERAPEUTICS may face longer learning curve for training and development of existing employees. This can open space for more nimble competitors in the field of Biotechnology & Drugs sector.

High dependence on third party suppliers

– OUTLOOK THERAPEUTICS high dependence on third party suppliers can disrupt its processes and delivery mechanism. For example -the current troubles of car makers because of chip shortage is because the chip companies started producing chips for electronic companies rather than car manufacturers.

Instability in the European markets

– European Union markets are facing three big challenges post Covid – expanded balance sheets, Brexit related business disruption, and aggressive Russia looking to distract the existing security mechanism. OUTLOOK THERAPEUTICS will face different problems in different parts of Europe. For example it will face inflationary pressures in UK, France, and Germany, balance sheet expansion and demand challenges in Southern European countries, and geopolitical instability in the Eastern Europe.

Regulatory challenges

– OUTLOOK THERAPEUTICS needs to prepare for regulatory challenges as consumer protection groups and other pressure groups are vigorously advocating for more regulations on big business - to reduce inequality, to create a level playing field, to product data privacy and consumer privacy, to reduce the influence of big money on democratic institutions, etc. This can lead to significant changes in the Biotechnology & Drugs industry regulations.

High level of anxiety and lack of motivation

– the Great Resignation in United States is the sign of broader dissatisfaction among the workforce in United States. OUTLOOK THERAPEUTICS needs to understand the core reasons impacting the Biotechnology & Drugs industry. This will help it in building a better workplace.

Backlash against dominant players

– US Congress and other legislative arms of the government are getting tough on big business especially technology companies. The digital arm of OUTLOOK THERAPEUTICS business can come under increasing regulations regarding data privacy, data security, etc.

Shortening product life cycle

– it is one of the major threat that OUTLOOK THERAPEUTICS is facing in Biotechnology & Drugs sector. It can lead to higher research and development costs, higher marketing expenses, lower customer loyalty, etc.

Stagnating economy with rate increase

– OUTLOOK THERAPEUTICS can face lack of demand in the market place because of Fed actions to reduce inflation. This can lead to sluggish growth in the economy, lower demands, lower investments, higher borrowing costs, and consolidation in the Biotechnology & Drugs industry.

Capital market disruption

– During the Covid-19, Dow Jones has touched record high. The valuations of a number of companies are way beyond their existing business model potential. This can lead to capital market correction which can put a number of suppliers, collaborators, value chain partners in great financial difficulty. It will directly impact the business of OUTLOOK THERAPEUTICS.

Trade war between China and United States

– The trade war between two of the biggest economies can hugely impact the opportunities for OUTLOOK THERAPEUTICS in Biotechnology & Drugs industry. The Biotechnology & Drugs industry is already at various protected from local competition in China, with the rise of trade war the protection levels may go up. This presents a clear threat of current business model in Chinese market.

Barriers of entry lowering

– As technology is more democratized, the barriers to entry to Biotechnology & Drugs industry are lowering. It can presents OUTLOOK THERAPEUTICS with greater competitive threats in the near to medium future. Secondly it will also put downward pressure on pricing throughout the Biotechnology & Drugs sector.

Technology disruption because of hacks, piracy etc

– The colonial pipeline illustrated, how vulnerable modern organization are to international hackers, miscreants, and disruptors. The cyber security interruption, data leaks, etc can seriously jeopardize the future growth of the organization.

Consumer confidence and its impact on OUTLOOK THERAPEUTICS demand

– There is a high probability of declining consumer confidence, given – high inflammation rate, rise of gig economy, lower job stability, increasing cost of living, higher interest rates, and aging demography. All the factors contribute to people saving higher rate of their income, resulting in lower consumer demand in Biotechnology & Drugs industry and other sectors.

---

Weighted SWOT Analysis of OUTLOOK THERAPEUTICS Template, Example

Not all factors mentioned under the Strengths, Weakness, Opportunities, and Threats quadrants in the SWOT Analysis are equal. Managers at OUTLOOK THERAPEUTICS needs to zero down on the relative importance of each factor mentioned in the Strengths, Weakness, Opportunities, and Threats quadrants. We can provide the relative importance to each factor by assigning relative weights. Weighted SWOT analysis process is a three stage process –

First stage for doing weighted SWOT analysis of OUTLOOK THERAPEUTICS is to rank the strengths and weaknesses of the organization. This will help you to assess the most important strengths and weaknesses of the firm and which one of the strengths and weaknesses mentioned in the initial lists are marginal and can be left out.

Second stage for conducting weighted SWOT analysis of OUTLOOK THERAPEUTICS is to give probabilities to the external strategic factors thus better understanding the opportunities and threats arising out of macro environment changes and developments.

Third stage of constructing weighted SWOT analysis of OUTLOOK THERAPEUTICS to provide strategic recommendations includes – joining likelihood of external strategic factors such as opportunities and threats to the internal strategic factors – strengths and weaknesses. You should start with external factors as they will provide the direction of the overall industry. Secondly by joining probabilities with internal strategic factors can help the company not only strategic fit but also the most probably strategic trade-off that OUTLOOK THERAPEUTICS needs to make to build a sustainable competitive advantage.

--- ---